Comparison Chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 USD | +5.47% |
|
+7.14% | -19.16% |
| 06-29 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +5.47% | +7.14% | -19.16% | +44.35% | -53.92% | 337M |  |  |  |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
